1 The eects of intrathecally (i.t.) injected kinin B 1 and B 2 receptor agonists and antagonists were measured on mean arterial pressure (MAP) and heart rate (HR) of conscious unrestrained spontaneously hypertensive rats (SHR of 16 weeks old) and age-matched normotensive Wistar Kyoto (WKY). Quantitative in vitro autoradiographic studies were also performed on the thoracic spinal cord of both strains with speci®c radioligands for B 2 receptors, [ ]-HOE 140 speci®c binding sites were found in all laminae of both strains. 5 It is concluded that the hypersensitivity of the cardiovascular response to BK is due to an increased number of B 2 receptors in the spinal cord of SHR and that B 1 receptors are unlikely involved in spinal cardiovascular regulation in SHR.
. Unlike the B 2 receptor which is constitutively expressed in many tissues, the B 1 receptor is generally absent in healthy animals or expressed in very low amount in a few tissues and cells. The B 1 receptor which is activated by des-Arg 9 -BK and des-Arg 10 -KD is inducible and functionally expressed in the presence of cytokines, bacterial lipopolysaccharides and following tissue injury (Marceau et al., 1998) . In addition to being involved in pain and in¯ammation (for review see Couture et al., 2001) ample evidence suggests a role for these peptides as neuromodulators and/or neurotransmitters in central cardiovascular regulation (Couture & Lindsey, 2000) . BK produces elevation of blood pressure when injected into the cerebral ventricles (CorreÃ a & Grae, 1974) or in more speci®c cardiovascular areas in the medulla such as the nucleus tractus solitarius and the paratrigeminal nucleus through the activation of B 2 receptor (Fior et al., 1993; Lindsey et al., 1997) .
In comparison to normotensive Wistar or WKY, SHR showed increased sensitivity to the pressor action of BK when injected into a lateral cerebral ventricle (BunÄ ag & Takahashi, 1981; Lindsey et al., 1988) , fourth cerebral ventricle (Lindsey et al., 1988; Martins et al., 1991; Lindsey, 1995) and the medulla (Privitera et al., 1994) . This hypersensitivity of the vasopressor response to BK in SHR was correlated with increased B 2 receptor binding sites in brain stem autonomic regions (Alvarez et al., 1992; Couture & Lindsey, 2000) . Although pharmacological studies with agonists and antagonists have led to the conclusion that the central pressor eect to BK is mediated only by the B 2 receptor, other studies suggest the implication of B 1 receptor in SHR (Alvarez et al., 1992; Emanueli et al., 1999) .
In the rat spinal cord, we reported that the intrathecal (i.t.) injection of BK increases arterial blood pressure via the activation of the sympatho-adrenal system and the B 2 receptor (Lopes & Couture, 1992; Lopes et al., 1993) . This was substantiated by autoradiographic studies which revealed the presence of B 2 but not B 1 receptor binding sites throughout the grey matter of the rat spinal cord (Lopes et al., 1995) . A preliminary study showed a 100% increase of B 2 receptor binding sites in the spinal dorsal horn of SHR when compared to WKY (Couture & Lindsey, 2000) .
The present study was undertaken to test the hypothesis that SHR are hypersensitive to the spinal cardiovascular eect of BK and that both B 1 and B 2 receptors are over expressed in the spinal cord of SHR. This was achieved with (i) a pharmacological approach by assessing the cardiovascular eects of selective B 1 and B 2 receptor agonists and antagonists intrathecally injected to the T-9 spinal cord segment in SHR and WKY; (ii) an anatomical analysis of the localization and quanti®cation of B 1 and B 2 receptor binding sites in the thoracic spinal cord of SHR and WKY by in vitro autoradiography.
Methods

Animal source and care
Male SHR (n=86) and Wistar Kyoto (n=60) were purchased at least 1 week prior to the study from Charles River, StConstant, QueÂ bec, Canada or Harlan, Indianapolis, IN, U.S.A. They were housed individually in plastic cages under a 12 h light-dark cycle in a room with controlled temperature (238C), humidity (50%) with food (Charles River Rodent) and tap water available ad libitum. The care of animals and research protocols were in compliance with the guiding principles for animal experimentation as enunciated by the Canadian Council on Animal Care and approved by the Animal Care Committee of our University.
Surgery
At the age of 15 ± 16 weeks old, rats were anaesthetized with an i.p. injection of 65 mg kg 71 sodium pentobarbitone (Somnotol; M.T.C. Pharmaceuticals, Cambridge, Ontario, Canada) and a polyethylene catheter (PE-10; Intramedics, Clay Adams, NJ, U.S.A.) was inserted into the spinal subarachnoid space via an incision made in the dura at the atlanto-occipital junction and pushed to the ninth thoracic segment (T-9) as described previously (Lopes & Couture, 1992) . About 20% of SHR and 40% of WKY were excluded from the study because they presented motor de®cit such as partial paralysis of one posterior or anterior leg. These rats were immediately humanely killed with an overdose of pentobarbital. Thereafter, the rats were allowed to recover in individual plastic cages (40623620 cm) and housed in the same controlled conditions. The correct positioning of the i.t. catheter was veri®ed by post-mortem examination at the end of experiment and the catheter was found either dorsally or laterally to the spinal cord.
Two days later, rats were re-anaesthetized with sodium pentobarbitone (65 mg kg 71 , i.p.) and an intravascular siliconized (Sigmacote, Sigma, St-Louis, MO, U.S.A.) PE-50 catheter, ®lled with physiological saline containing 100 IU ml 71 heparin sodium salt (Sigma, St-Louis, MO, U.S.A.), was inserted into the abdominal aorta through the femoral artery for direct blood pressure recording and exteriorized at the back of the neck. Before intrathecal and vascular surgery, the animals received antibiotics Trimethoprime and Sulfadiazine (tribissen 24%, 30 mg kg 71 , s.c., Schering Canada Inc., Pointe Claire, QueÂ bec, Canada). Ketoprophen was given during the ®rst surgery only (anafen, 5 mg kg 71 , s.c., Merial Canada Inc., Baie d'UrfeÂ , QueÂ bec, Canada). Recovery from anaesthesia was monitored closely under a warming lamp to maintain the body temperature of animals. Thereafter, rats were housed individually in polyethylene cage with a top grid and returned to their resident room. Experimental protocols were initiated 24 h later, in awake and unrestrained rats.
Measurement of cardiovascular parameters
Blood pressure and heart rate were measured respectively with a Statham pressure Transducer (P23ID) and a cardiac tachometer (model 7P4) (triggered by the arterial blood pressure pulse) coupled to a Grass polygraph (model 79; Grass Instruments Co., Quincy, MA, U.S.A.). The cardiovascular response was measured 1 h after the rats were transported to the testing room. They remained in their resident cage but the top grid was removed and had no more access to the food and water for the duration of experiment. When resting blood pressure and heart rate were stable, rats received an i.t. injection of 20 ml arti®cial cerebrospinal¯uid (aCSF). The void volume of the i.t. catheter was 10 ml. Only rats (99%) which did not show cardiovascular changes to aCSF for the 30 min period were selected in the study. -BK (8.1, 81, 810 and 8100 pmol) to construct a complete doseresponse curve. Each rat was injected randomly with one of the two agonists on the ®rst day and the second agonist was given on the subsequent day. Increasing doses of BK or desArg 9 -BK were given at 40 ± 60 min intervals. During the course of the study, a subpopulation of SHR and WKY was insensitive to des-Arg 9 -BK (8100 pmol). Some of these rats were therefore injected randomly at 40 ± 60 min apart with two other B 1 receptor agonists Lys-des-Arg -BK (8100 pmol), and BK (8.1 pmol) was injected as positive control. Peptides were administered in a volume of 10 ml of vehicle. The peptide and the aCSF ush (10 ml) were given within a total period of 60 s to avoid any compression of spinal cord. Changes in MAP and HR represent the dierence between recordings obtained 30 s before the start of injection and the value at the designed time after injection. Each dose was calculated in a volume of 10 ml solution injected intrathecally.
Experimental protocols
Eects of i.t. kinin receptor antagonists SHR (n=7 ± 10) and WKY (n=7 ± 10) initially received either 8100 pmol des-Arg 9 -BK or 8.1 pmol BK and 1 h after were given i.t. one of the following antagonists: 81 pmol [des-Arg dose (810 and 8100 pmol) was tested against the agonist 1 h later. The agonist was re-injected alone 24 h later to assess the reversibility of any blockade observed with the antagonist on the preceding day. Only one antagonist was given to a rat.
Eect of a systemic treatment with a prostaglandin synthesis inhibitor SHR (n=6) and WKY (n=3) initially received randomly an i.t. injection of des-Arg 9 -BK (8100 pmol) and BK (8.1 pmol) at 1 h apart. The same dose of each agonist was re-injected 1 h after treatment with indomethacin (5 mg kg 71 , i.a.).
Tissue preparation for autoradiography SHR (n=4) and WKY (n=4) of 16 weeks old were sacri®ced by asphyxia under CO 2 inhalation and subjected to a dorsal laminectomy. An incision of the dura-mater was made carefully to remove the thoracic spinal cord (T8-T11). Then, the pieces were immediately frozen in 2-methylbutane at 7508C and stored at 7808C. Matched spinal cord segments from T9 to T10 of 4 SHR and 4 WKY were separately mounted in two gelatine blocs and serially cut into 20 mm thick coronal sections with a cryostat (711 to 7138C). Slices obtained from each grouped spinal cords were thaw-mounted on 0.2% gelatine/ 0.033% chromium potassium sulphate coated slides (50 slides 68 sections rat
71
). Sections were kept at 7808C until use.
In vitro receptor autoradiography The non-speci®c binding was assessed in the presence of 1 mM of unlabelled peptide. To ascertain the speci®city of the labelled B 2 radioligand, the same concentration of unlabelled B 1 ligand was added to the solution. Likewise, the same concentration of the unlabelled B 2 ligand was added to the labelled B 1 ligand solution. At the end of the incubation period, slides were transferred sequentially through four rinses of 4 min each in PIPES-NH 4 OH buer at 48C and rapidly dipped into cold distilled water to remove excess of salts. Sections were air-dried and juxtaposed against 
Quantification of receptor binding sites
The autoradiograms were quanti®ed by densitometry using the MCID image analysis system (Imaging Research Inc., Ontario, Canada). Quanti®cation was performed on 264 sections (saturation curves) or 400 sections (the remainder of the study) for each spinal cord on both sides. The speci®c binding was determined by digital subtraction of the nonspeci®c binding from the total binding of adjacent sections except for the saturation curves the speci®c binding was determined by mathematical subtraction. The results represent the mean+s.e.mean of four animals per group and are expressed in fmol mg 71 tissue. The anatomical limits and nomenclature were determined in conformity with Paxinos & Watson (1998) (Figure 2 ).
Drugs and solutions
The composition of aCSF was (in mM) NaCl 128.6, KCl 2.6, MgCl 2 2.0 and CaCl 2 1.4; pH adjusted to 7. (Murone et al., 1996) was derived from the B 2 antagonist Hoe 140 (Hock et al., 1991) . Both kinin receptor ligands were synthesized in the laboratory of Dr D. Regoli (Department of Pharmacology, Sherbrooke University, Sherbrooke, QueÂ -bec, Canada) and iodinated by the chloramine T method (Hunter & Greenwood, 1962) (n=4) and WKY (n=4) as a function of its concentration. Quanti®cation was performed on 96 sections (24 sections per animal) for each concentration corresponding to 1056 sections for total and non-speci®c binding. Speci®c binding is calculated as the mathematical dierence between total and non-speci®c binding (which persists in the presence of 1 mM of unlabelled ligand) and re¯ects the amount of radioligand bound to speci®c B 2 receptor binding sites (upper panel). The anity of the binding, which is expressed as a dissociation constant (K d ), was calculated as the concentration of B 2 radioligand that results in 50% of maximal speci®c binding (lower panel).
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Spinal effect of BK on the cardiovascular system
The eects of four increasing doses of BK on MAP and HR in SHR and WKY are depicted in Figure 3 . In SHR, BK caused two dierent cardiovascular responses which could not be associated to the position of the intrathecal catheter. In the ®rst group (n=9), BK (8.1 to 810 pmol) caused triphasic changes in MAP. After an initial and marked increase of MAP, a transient drop occurred for 45 s and thereafter the pressor eect lasted about 5 min before returning gradually to baseline level during the following 10 min. These changes were accompanied by a biphasic eect on HR (Figure 3a) ), respectively. Only an increase in blood pressure occurred in all these rats and no transient drop in blood pressure was seen following the initial increase.
In WKY (n=7), BK (0.81 ± 810 pmol) produced short increases in MAP accompanied either by bradycardia ( Figure  3b ) or tachycardia in three rats (data not shown). The pressor response to BK was statistically signi®cant when compared to 
, P50.01), 8.1 pmol (0.5 ± 2 min, P50.01), 81 and 810 pmol (0.5 ± 2 min, P50.05). The maximal pressor responses evoked by BK in SHR were signi®cantly higher than those evoked by similar doses of BK in WKY although maximal bradycardia were not signi®cantly dierent at any doses between both strains (Figure 4a ).
Spinal effect of des-Arg 9 -BK on the cardiovascular system Des-Arg 9 -BK caused inconsistent cardiovascular responses throughout the study which could not be attributed to the position of the intrathecal catheter. Whereas it increased signi®cantly MAP at 810 and 8100 pmol in SHR (n=8) and at the highest dose in WKY (n=7) with a similar bradycardia in both strains (Figure 4b ), des-Arg 9 -BK also produced tachycardic responses or no cardiovascular changes in several SHR and WKY even if BK (8.1 pmol) had a cardiovascular eect in all tested animals. Thus we pooled all the rats which were tested with des-Arg 9 -BK in the dierent protocols to better highlight the variability of the B 1 -induced cardiovascular response (Tables 1 and 2 ). The two other B 1 agonists induced consistent increases in MAP and HR in SHR which failed to be activated by des-Arg 9 -BK (Table 1 ). In WKY which were insensitive to des-Arg 9 -BK, the B 1 agonists were either inactive (Lys-des-Arg 
Effect of indomethacin in SHR and WKY
The cyclo-oxygenase inhibitor, indomethacin (5 mg kg 71 , i.a. 1 h earlier), did not aect the increases in MAP and HR evoked by 8100 pmol des-Arg 9 -BK or 8.1 pmol BK in both SHR ( Figure 8 ) and WKY (data not shown). Moreover, indomethacin had no direct eect on baseline values (data not shown).
Behavioural responses to kinins
Concomitant with the cardiovascular eects, i.t. injection of BK and des-Arg 9 -BK induced behavioural responses in SHR and WKY. For a period that lasted up to 1 min after injection of agonists, the rat became restless and showed exploratory activity at all doses which produced cardiovascular eects. A lateral rocking motion on the posterior limbs was also observed in most of the rats. Behavioural responses induced by des-Arg 9 -BK were less striking than those elicited by BK. The initial behavioural excitation induced by BK was followed by a period of sedation which lasted for more than 15 min. Whereas vocalization was observed at 810 pmol BK in some WKY, all SHR displayed a sharp episode of vocalization and jumping during the ®rst 30 s. Behavioural responses induced by des-Arg 
Autoradiographic distribution of kinin receptors in thoracic spinal cord of SHR and WKY
Quantitative in vitro autoradiography was performed to analyse the distribution of B 2 and B 1 receptors in the thoracic spinal cord (T9-T10) of 16 weeks old SHR (n=4) and age-matched WKY (n=4). The overall anatomical distribution of both kinin receptor binding sites is illustrated in Figure 9 . Analysis of the autoradiograms from WKY showed that the [ (Figure 10a ). Levels of speci®c B 2 receptor binding sites were signi®cantly higher in SHR in most laminae with Table 1 Comparison of the dierent maximal responses in mean arterial pressure (DMAP) and heart rate (DHR) elicited by B 1 receptor agonists injected at the dose of 8.1 nmol to the T-9 spinal cord segment of SHR 
Discussion
Spontaneously hypertensive rats are more sensitive than normotensive rats to the pressor action of BK injected either intracerebrally or in speci®c cardiovascular centres of the brain stem (for review see Couture & Lindsey, 2000) . In the present study, we show that the cardiovascular response to BK is also greater at the level of the spinal cord in SHR. This hypersensitivity is characterized by enhanced amplitude and duration of the vasopressor eect induced by intrathecal BK in SHR as compared to WKY. Moreover, the threshold dose for BK is 10 fold lower in SHR. Data with B 2 receptor antagonist Hoe 140 con®rm that the cardiovascular response mediated by BK in the spinal cord of SHR and WKY is mediated by B 2 receptors as already reported in Wistar rats and streptozotocin (STZ)-diabetic rats (Lopes et al., 1993; Cloutier & Couture, 2000) .
Since the spinal action of BK on blood pressure was attributable to the release of catecholamines from sympathetic ®bers and the adrenal medulla in Wistar rats (Lopes & Couture, 1992) , it is likely that the elevation of blood pressure in SHR is also due to the release of peripheral catecholamines. The activity and reactivity of the sympathetic nervous system is well documented in SHR (de Champlain, 1990) . Thus, it is likely that the greater vasopressor eects mediated by spinal BK derive from an exaggerated sympatho-adrenal medullary response. The mechanism underlying the rapid oset of the pressor response has not been investigated in this study but could derive from the activation of vascular b 2 -adrenoceptors similarly to the compensatory skeletal muscle vasodilatory mechanism occurring during the defence response in SHR (Kirby & Johnson, 1990; Kirby et al., 1991) . This Spinal kinin receptors in hypertension F. Cloutier et alhypothesis is also predicted by the presence of a badrenoceptor component in the spinal vasodepressor response to BK under systemic a 1 -adrenoceptor inhibition (Lopes & Couture, 1992) . Hence, the activation of badrenoceptors in the skeletal muscle vasculature by circulating adrenaline may blunt large pressor responses to spinal BK in SHR.
Previous study in Wistar rats has shown that the bradycardia produced by i.t. injection of BK is due to a vagal re¯ex involving sensory C-®bres and a spinobulbar pathway (Lopes & Couture, 1992) . Whereas most WKY responded to BK by a bradycardia, SHR displayed either a biphasic eect on HR or a tachycardia under stimulation with BK. Since atropine converted the BK-induced bradycardia into a tachycardia in Wistar rats (Lopes & Couture, 1992) , it is likely that the sympathetic drive to the heart predominates over the parasympathetic component in SHR. This would mean that the baroreceptor re¯ex which normally occurs under increases of blood pressure is impaired in SHR and is substituted by a greater sympathetic drive (Nosaka & Okamoto, 1970; Gonzalez et al., 1983) .
Site of action of intrathecal kinins
The cardiovascular responses induced by BK and B 1 agonists had a rapid onset, suggesting an action directly at the segment of injection in the spinal cord. Indeed, the biological half-life of BK after i.t. injection is thought to be as short as that reported (530 s) after intracerebroventricular (i.c.v.) administration in conscious rats (Kariya et al., 1982) . Although the biological half-life of des-Arg 9 -BK in the CSF remains unknown, this fragment of BK is also a substrate for kininase II (DeÂ carie et al., 1996), the major metabolic pathway for kinins. Peripheral leakage of the injected peptide into systemic circulation cannot account for the cardiovascular responses to kinins because BK produces vasodepressor responses in the periphery contrary to its spinal vasopressor eect (Regoli & BarabeÂ , 1980) . Previous studies using dyes and radiotracers have documented that drugs and peptides injected to rats by an i.t. catheter do not reach supraspinal structures within the time frame of the experiments (Yaksh & Rudy, 1976; Cridland et al., 1987) . ]-HPP-Hoe 140 binding sites in the thoracic spinal cord was similar in WKY and SHR and was found to be predominantly located to the dorsal horn as previously reported in Wistar rats (Lopes et al., 1995) . It is worth noting that in Wistar rats, the highest density of B 2 receptor binding sites was located in lamina II when using Notwithstanding that dierential laminar distribution between strains, the presence of B 2 receptor binding sites on primary sensory terminals in the super®cial layers of the dorsal horn correlates well with the putative role of BK in the mediation of nociceptive information . In the present study, BK induced higher nociceptive behavioural excitation in SHR which is consistent with the higher density of [ 125 I]-HPP-Hoe 140 binding sites in laminae I and II of the spinal dorsal horn in SHR. This may appear to be in disagreement with the increased response threshold to noxious stimuli and hypoalgesia reported in human and animals aected with chronic hypertension (Ghione, 1996) . However, the activation of B 2 receptor in the rat spinal horn also produces antinociceptive responses through the activation of bulbospinal noradrenergic inhibitory ®bres (Laneuville et al., 1989) which is congruent with the period of sedation evoked by intrathecal BK in the present study. Further studies are however needed to address the relative contribution of the dual eects of kinins on nociception in hypertension.
A moderate density of [ -BK binding sites was also reported in the IML (Lopes et al., 1995) . This region corresponds to the site of origin of the pre-ganglionic sympathetic neurons which provide an anatomical substrate for the spinal eect of BK on the cardiovascular system. The possibility that the enhanced density of B 2 receptor binding sites seen in SHR is linked to a strain dierence or to hypertension will require further studies with other models of hypertension. Nevertheless, we found in a recent study that B 2 receptor binding sites were signi®cantly increased in the spinal cord of SHR from the age of 8 to 16 weeks when compared to age-matched WKY and this dierence between strains was not aected by preventing the development of hypertension following treatment with an anti-hypertensive agent (losartan, antagonist of angiotensin AT 1 receptor) from the age of 4 to 16 weeks (Ongali et al., 2001) . This ®nding suggests that the up-regulation of B 2 receptors in SHR is not secondary to hypertension but to a genetic feature. Thus, one cannot exclude the possibility that spinal kinins and B 2 receptors are involved somehow in the development of hypertension.
Lack of evidence for B 1 receptor in the spinal action of kinins in SHR and WKY In SHR and WKY, des-Arg 9 -BK increased blood pressure and caused either bradycardia or tachycardia. This cardiovascular response appears to be related to the activation of B 2 receptors in both strains. First, des-Arg 9 -BK was 1000 fold less potent than BK in producing changes in HR and MAP. This is consistent with the fact that this B 1 agonist has less than 1% the anity of BK on peripheral B 2 receptor (Regoli & BarabeÂ , 1980) . Second, the spinal eects of desArg 9 -BK were abolished by the B 2 receptor antagonist, Hoe 140 (Hock et al., 1991) , at relatively low doses (81 pmol). Spinal kinin receptors in hypertension F. Cloutier et albeen described as B 1 receptor antagonist with little anity for B 2 receptor , it can block the response mediated by BK in the nanomolar range (Seabrook et al., 1997) . It is also unlikely that BK is converted into des-Arg -Hoe 140 are not highly selective agonist and antagonist at the B 1 receptor when used at high doses (nmol range). However, the two radioligands which were used to probe B 1 and B 2 receptors displayed a high selectivity when employed in the pmol range.
The cardiovascular response to des-Arg 9 -BK displayed a large variability among animals as several SHR and WKY were insensitive to this agonist despite responding to a low dose of BK (8.1 pmol) . The more consistent cardiovascular eects seen with Lys-des-Arg -BK is a stable peptide agonist protected by angiotensin-1 converting enzyme and aminopeptidase M (Drapeau et al., 1991) . Although the biological half-life of des-Arg 9 -BK in the CSF remains unknown, this fragment of BK is also a substrate for kininase II (DeÂ carie et al., 1996) .
Pharmacological evidence indicates that the B 1 receptor is up-regulated in the spinal cord of STZ-diabetic rats (Cloutier & Couture, 2000) . ]-Hoe 140) and B 2 receptor (Hoe 140) tested in this study had no direct eect on blood pressure and heart rate upon their i.t. administration, it is unlikely that these receptors are involved in the tonic control of blood pressure at the level of the spinal cord in SHR and WKY. A similar conclusion was drawn in Wistar rats (Lopes et al., 1993) and STZ-diabetic rats (Cloutier & Couture, 2000) . However, it is feasible that kinins act as neuromodulators of spinal autonomic functions.
Conclusion
The hypersensitivity of the pressor response to BK and the higher densities of B 2 receptor binding sites provide evidence for an up-regulation of B 2 receptors in the spinal cord of SHR. Also this pharmacologic and quantitative autoradiographic study makes unlikely a role for B 1 receptor in spinal autonomic control of blood pressure in SHR and WKY.
